Lista de obras -

A Cross-Reactive Small Protein Binding Domain Provides a Model to Study Off-Tumor CAR-T Cell Toxicity

scientific article published on 14 April 2020

Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes

artículo científico publicado en 2012

Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer

artículo científico publicado en 2020

Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study

artículo científico publicado en 2018

BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma

artículo científico publicado en 2012

CD103 and Intratumoral Immune Response in Breast Cancer

artículo científico publicado en 2016

CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer

artículo científico publicado en 2012

CD74 and intratumoral immune response in breast cancer

artículo científico publicado en 2016

CD8+ T cells induce complete regression of advanced ovarian cancers by an interleukin (IL)-2/IL-15 dependent mechanism

artículo científico publicado en 2007

Changes in the Tumor Immune Microenvironment during Disease Progression in Patients with Ovarian Cancer

artículo científico publicado en 2020

Clonal evolution of high-grade serous ovarian carcinoma from primary to recurrent disease

artículo científico publicado en 2012

Co-expression patterns of chimeric antigen receptor (CAR)-T cell target antigens in primary and recurrent ovarian cancer

artículo científico publicado en 2020

Correction: Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors.

artículo científico publicado en 2013

Density of tumour stroma is correlated to outcome after adoptive transfer of CD4+ and CD8+ T cells in a murine mammary carcinoma model

artículo científico publicado en 2009

Epithelial tumor suppressor ELF3 is a lineage-specific amplified oncogene in lung adenocarcinoma

artículo científico publicado en 2019

Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer.

artículo científico publicado en 2017

Hyperspectral cell sociology reveals spatial tumor-immune cell interactions associated with lung cancer recurrence

scholarly article by Katey S S Enfield et al published 16 January 2019 in Journal for Immunotherapy of Cancer

Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell Infiltration

scientific article published on 07 November 2019

Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer

artículo científico publicado en 2018

Intratumoral Immune Responses Can Distinguish New Primary and True Recurrence Types of Ipsilateral Breast Tumor Recurrences (IBTR)

artículo científico publicado en 2011

Investigation of PD-L1 Biomarker Testing Methods for PD-1 Axis Inhibition in Non-squamous Non-small Cell Lung Cancer

artículo científico publicado en 2016

Location, location, location: CD103 demarcates intraepithelial, prognostically favorable CD8(+) tumor-infiltrating lymphocytes in ovarian cancer

artículo científico publicado en 2014

Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers

artículo científico publicado en 2018

Mammary tumors with diverse immunological phenotypes show differing sensitivity to adoptively transferred CD8+ T cells lacking the Cbl-b gene

artículo científico publicado en 2009

Molecular Subtype Not Immune Response Drives Outcomes in Endometrial Carcinoma

artículo científico publicado en 2018

Neoadjuvant Chemotherapy of Ovarian Cancer Results in Three Patterns of Tumor-Infiltrating Lymphocyte Response with Distinct Implications for Immunotherapy

artículo científico publicado en 2016

PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian Cancer

artículo científico publicado en 2015

PD-L1 and intratumoral immune response in breast cancer

artículo científico publicado en 2017

PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer

artículo científico publicado en 2016

Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (alphaE/beta7 Integrin) in high-grade serous ovarian cancer

artículo científico publicado en 2010

Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma

artículo científico publicado en 2017

Recurrent genomic rearrangements in primary testicular lymphoma.

artículo científico

Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma

artículo científico publicado en 2019

Somatic mutation-associated T follicular helper cell elevation in lung adenocarcinoma

artículo científico publicado en 2018

Spontaneous Mammary Tumors Differ Widely in Their Inherent Sensitivity to Adoptively Transferred T Cells

scientific article published on 01 July 2007

Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer.

artículo científico publicado en 2013

Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors

artículo científico publicado en 2009

The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity

artículo científico publicado en 2018

The immune suppressive factors CD155 and PD-L1 show contrasting expression patterns and immune correlates in ovarian and other cancers

scientific article published on 20 May 2020

Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer

artículo científico publicado en 2016

Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer

artículo científico publicado en 2008

Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer

artículo científico publicado en 2013

Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer.

artículo científico publicado en 2011

Lista de obras de

A Cross-Reactive Small Protein Binding Domain Provides a Model to Study Off-Tumor CAR-T Cell Toxicity

Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes

Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer

Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study

BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma

CD103 and Intratumoral Immune Response in Breast Cancer

CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer

CD74 and intratumoral immune response in breast cancer

CD8+ T cells induce complete regression of advanced ovarian cancers by an interleukin (IL)-2/IL-15 dependent mechanism

Changes in the Tumor Immune Microenvironment during Disease Progression in Patients with Ovarian Cancer

Clonal evolution of high-grade serous ovarian carcinoma from primary to recurrent disease

Co-expression patterns of chimeric antigen receptor (CAR)-T cell target antigens in primary and recurrent ovarian cancer

Correction: Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors.

Density of tumour stroma is correlated to outcome after adoptive transfer of CD4+ and CD8+ T cells in a murine mammary carcinoma model

Epithelial tumor suppressor ELF3 is a lineage-specific amplified oncogene in lung adenocarcinoma

Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer.

Hyperspectral cell sociology reveals spatial tumor-immune cell interactions associated with lung cancer recurrence

Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell Infiltration

Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer

Intratumoral Immune Responses Can Distinguish New Primary and True Recurrence Types of Ipsilateral Breast Tumor Recurrences (IBTR)

Investigation of PD-L1 Biomarker Testing Methods for PD-1 Axis Inhibition in Non-squamous Non-small Cell Lung Cancer

Location, location, location: CD103 demarcates intraepithelial, prognostically favorable CD8(+) tumor-infiltrating lymphocytes in ovarian cancer

Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers

Mammary tumors with diverse immunological phenotypes show differing sensitivity to adoptively transferred CD8+ T cells lacking the Cbl-b gene

Molecular Subtype Not Immune Response Drives Outcomes in Endometrial Carcinoma

Neoadjuvant Chemotherapy of Ovarian Cancer Results in Three Patterns of Tumor-Infiltrating Lymphocyte Response with Distinct Implications for Immunotherapy

PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian Cancer

PD-L1 and intratumoral immune response in breast cancer

PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer

Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (alphaE/beta7 Integrin) in high-grade serous ovarian cancer

Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma

Recurrent genomic rearrangements in primary testicular lymphoma.

Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma

Somatic mutation-associated T follicular helper cell elevation in lung adenocarcinoma

Spontaneous Mammary Tumors Differ Widely in Their Inherent Sensitivity to Adoptively Transferred T Cells

Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer.

Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors

The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity

The immune suppressive factors CD155 and PD-L1 show contrasting expression patterns and immune correlates in ovarian and other cancers

Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer

Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer

Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer

Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer.